CY1108495T1 - Μη στεροειδεις ρυθμιστες υποδοχεων προγεστερονης - Google Patents

Μη στεροειδεις ρυθμιστες υποδοχεων προγεστερονης

Info

Publication number
CY1108495T1
CY1108495T1 CY20081101280T CY081101280T CY1108495T1 CY 1108495 T1 CY1108495 T1 CY 1108495T1 CY 20081101280 T CY20081101280 T CY 20081101280T CY 081101280 T CY081101280 T CY 081101280T CY 1108495 T1 CY1108495 T1 CY 1108495T1
Authority
CY
Cyprus
Prior art keywords
adjusters
non steroid
progesteron receptor
prodrug
progesteron
Prior art date
Application number
CY20081101280T
Other languages
English (en)
Inventor
Pedro Harold Han Hermkens
Hans Lucas
Paul Peter Marie Antonious Dols
Johannes Bernardus Maria Rewinkel
Brigitte Johanna Bernita Folmer
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1108495T1 publication Critical patent/CY1108495T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει ενώσεις σύμφωνα με το γενικό τύπο (Ι), ένα προφάρμακο τους, ένα φαρμακευτικά αποδεκτό άλας τους, ή ένα φαρμακευτικά αποδεκτό άλας ενός προφαρμάκου τους. Ειδικότερα, η παρούσα εφεύρεση παρέχει μη στερεοειδείς ενώσεις εξαιρετικής συγγένειας οι οποίες είναι αγωνιστές, μερικώς αγωμνιστές ή ανταγωνιστές του υποδοχέα προγεστερόνης.
CY20081101280T 2002-04-04 2008-11-10 Μη στεροειδεις ρυθμιστες υποδοχεων προγεστερονης CY1108495T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076350 2002-04-04
EP03720570A EP1495030B1 (en) 2002-04-04 2003-04-01 Non-steroidal progesterone receptor modulators

Publications (1)

Publication Number Publication Date
CY1108495T1 true CY1108495T1 (el) 2014-04-09

Family

ID=28685924

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101280T CY1108495T1 (el) 2002-04-04 2008-11-10 Μη στεροειδεις ρυθμιστες υποδοχεων προγεστερονης

Country Status (30)

Country Link
US (1) US7737136B2 (el)
EP (1) EP1495030B1 (el)
JP (1) JP4418683B2 (el)
KR (1) KR100965173B1 (el)
CN (1) CN1279044C (el)
AR (1) AR039251A1 (el)
AT (1) ATE404567T1 (el)
AU (1) AU2003224161B2 (el)
BR (1) BR0308890A (el)
CA (1) CA2480940C (el)
CY (1) CY1108495T1 (el)
DE (1) DE60322867D1 (el)
DK (1) DK1495030T3 (el)
EC (1) ECSP045334A (el)
ES (1) ES2310654T3 (el)
HK (1) HK1070362A1 (el)
HR (1) HRP20040913A2 (el)
IL (2) IL164169A0 (el)
IS (1) IS7452A (el)
MX (1) MXPA04009709A (el)
NO (1) NO20044473L (el)
NZ (1) NZ535546A (el)
PE (1) PE20040350A1 (el)
PL (1) PL372846A1 (el)
PT (1) PT1495030E (el)
RU (1) RU2309155C2 (el)
SI (1) SI1495030T1 (el)
TW (1) TWI297685B (el)
WO (1) WO2003084963A1 (el)
ZA (1) ZA200407667B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
TWI370129B (en) * 2005-02-14 2012-08-11 Msd Oss Bv Non steroidal glucocorticoid receptor modulators
TWI375676B (en) * 2005-08-29 2012-11-01 Msd Oss Bv Non-steroidal glucocorticoid receptor modulators
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
CN101522689B (zh) * 2006-09-27 2012-01-11 欧加农股份有限公司 吡啶并氧氮杂*孕酮受体调节剂
TW200914029A (en) * 2007-05-07 2009-04-01 Organon Nv New progesterone receptor modulators
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054572A (en) * 1973-04-26 1977-10-18 Akzona Incorporated Hexahydro pyridine [1,2d] dibenza [b,f] (1,4)-diazepines
NL7305811A (el) 1973-04-26 1974-10-29
US4016161A (en) * 1974-04-24 1977-04-05 Akzona Incorporated Amino-substituted 1,2,3,4,10,146-hexahydro-pyridino[1,2-a]dibenzo[c,f]azepines
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
CA2026856A1 (en) 1989-10-05 1991-04-06 Mark G. Bock 3-substituted-1,4-benzodiazepines useful as oxytocin
US5688810A (en) 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
TW358031B (en) 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
TWI370129B (en) 2005-02-14 2012-08-11 Msd Oss Bv Non steroidal glucocorticoid receptor modulators
CN101522689B (zh) 2006-09-27 2012-01-11 欧加农股份有限公司 吡啶并氧氮杂*孕酮受体调节剂

Also Published As

Publication number Publication date
PE20040350A1 (es) 2004-06-17
TWI297685B (en) 2008-06-11
IS7452A (is) 2004-09-16
EP1495030B1 (en) 2008-08-13
ATE404567T1 (de) 2008-08-15
AR039251A1 (es) 2005-02-16
WO2003084963A1 (en) 2003-10-16
SI1495030T1 (sl) 2009-02-28
CN1279044C (zh) 2006-10-11
CN1649879A (zh) 2005-08-03
PT1495030E (pt) 2008-11-21
HK1070362A1 (en) 2005-06-17
ZA200407667B (en) 2006-07-26
US20050171087A1 (en) 2005-08-04
KR20040099396A (ko) 2004-11-26
US7737136B2 (en) 2010-06-15
EP1495030A1 (en) 2005-01-12
AU2003224161B2 (en) 2009-02-26
IL164169A (en) 2010-11-30
NO20044473L (no) 2004-10-29
RU2309155C2 (ru) 2007-10-27
ECSP045334A (es) 2004-11-26
KR100965173B1 (ko) 2010-06-24
HRP20040913A2 (en) 2005-08-31
IL164169A0 (en) 2005-12-18
MXPA04009709A (es) 2004-12-13
NZ535546A (en) 2007-01-26
ES2310654T3 (es) 2009-01-16
JP4418683B2 (ja) 2010-02-17
BR0308890A (pt) 2005-01-11
DE60322867D1 (de) 2008-09-25
PL372846A1 (en) 2005-08-08
DK1495030T3 (da) 2008-11-24
AU2003224161A1 (en) 2003-10-20
CA2480940C (en) 2011-02-08
JP2005528382A (ja) 2005-09-22
RU2004132215A (ru) 2005-04-20
CA2480940A1 (en) 2003-10-16
TW200307675A (en) 2003-12-16

Similar Documents

Publication Publication Date Title
CY1108495T1 (el) Μη στεροειδεις ρυθμιστες υποδοχεων προγεστερονης
DK1776377T3 (da) Nyt steroid til FXR
CY1110362T1 (el) Ν-(2-αρυλαιθυλο)βενζυλαμινες ως ανταγωνιστες του 5-ητ6 υποδοχεα
CY1111876T1 (el) Νεες πυρρολες με υπολiπiδaiμiκες και υποχοληστερολαιμικες δραστικοτητες, μεθοδος για την παρασκευη αυτων και φαρμακευτικες συνθεσεις που τις περιεχουν και η χρηση αυτων στην ιατρικη
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
NO20041504L (no) Lactamderivater som antagonister for humane 11CBY reseptorer.
CY1106424T1 (el) Παραγωγα ν-φαινυλ-πυρρολ γουανιδινης ως συνδετες υποδοχεις μελανοκορτινης
CY1109656T1 (el) Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης
ECSP034640A (es) Derivados de feniletenilo o feniletinilo como antagonistas del receptor del glutamato
CY1109015T1 (el) Διφαινυλ ενωσεις χρησιμες ως ανταγωνιστες μουσκαρινικου υποδοχεα
CY1105603T1 (el) Συνεργιστικοι συνδυασμοι που περιλαμβανουν εναν αναστολεα της ρενινης, για καρδιαγγειακες νοσους
CR11036A (es) Derivados y composiciones de isoindol 4' -o- sustituidos, composiciones que las comprenden y metodos de uso de los mismos
CY1113029T1 (el) Παραγωγα αζαδικυκλο [3.1.0] εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
CY1113352T1 (el) Ενωση σπειρο-δακτυλιου και χρηση αυτης για ιατρικους σκοπους
ECSP034744A (es) Antagonistas de nmda/nr2b no arilo-heterociclico n-sustituidos
CY1109543T1 (el) Βασικοι μη-πεπτιδικοι ανταγωνιστες βραδυκινινης και 5 φαρμακευτικες συνθεσεις απο αυτους
CY1109860T1 (el) Παραγοντες υποδοχεα ισταμινης η3, παρασκευη και θεραπευτικες χρησεις
CY1111125T1 (el) Υποκατεστημενα παραγωγα δικυκλικης πυριμιδονης
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
EA200401455A1 (ru) Производные бензоксазина в качестве модуляторов 5-htи их применение
CY1124032T1 (el) Παραγωγα 3-μεθυλο-πυρρολιδινο-2,5-διονης χρησιμα ως ανταγωνιστες του υποδοχεα cgrp
CY1109038T1 (el) Μη στεροειδεις ρυθμιστες υποδοχεα γλυκοκορτικοειδων
MXPA05013149A (es) Derivados de imidazol como antagonistas del receptor de glutamato.
DE602004023926D1 (de) Selektive spirocyclische glucocorticoid-rezeptor-modulatoren